Pancreatic Cancer Trial, Recruiting NCT03855800 Sponsor: Mayo Clinic Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT03855800
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have fluid-filled sacs (cysts) in the pancreas that meet specific concern levels known as "Fukuoka worrisome" or "Fukuoka high-risk" criteria (confirm with trial site for what this means in your case)
  • People who are suspected to have a type of cyst in the pancreas that may be a growth or tumour
  • People who are able to sign a written consent form agreeing to take part

Who may not be able to join:

  • People who are pregnant or currently breastfeeding
  • People who are currently incarcerated
  • People whose scans or imaging suggest they may already have pancreatic cancer
  • People who have a previous history of pancreatic cancer or have had surgery on their pancreas
  • People who have received chemotherapy (cancer-treating medication given throughout the body) or radiation therapy to the abdomen in the last 5 years
  • People who have previously received any treatment directed at a pancreatic cyst
  • People who have a history of pancreatic necrosis (serious damage or death of pancreatic tissue)
  • People who have been diagnosed with any cancer — other than a common type of non-serious skin cancer (non-melanoma skin cancer) — within the last 5 years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shounak Majumder, MD, Mayo Clinic

Phone: 1-833-250-5364

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
11 May 2018
Est. completion
30 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Biospecimen Acquisition; High grade dysplasia (HGD) or cancer diagnosis in Immediate Surgery group

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov